Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European Cohort

Annals of Oncology

Volumn 24, Issue 9, 2013, Pages 2449-2455

  Schlesinger, S ^a,b   Aleksandrova, K ^b   Pischon, T ^b,c   Jenab, M ^d   Fedirko, V ^d,e   Trepo, E ^f   Overvad, K ^g   Roswall, N ^h   Tjonneland A ^h   Boutron Ruault, M C ^i,j,k   Fagherazzi, G ^i,j,k   Racine, A ^i,j,k   Kaaks, R ^l   Grote, V A ^l   Boeing, H ^b   Trichopoulou, A ^m,n   Pantzalis, M ⁿ   Kritikou, M ⁿ   Mattiello, A ^o   Sieri, S ^p   Sacerdote, C ^q   Palli, D ^r   Tumino, R ^s   Peeters, P H ^t,u   Bueno de Mesquita, H B ^t,v   Weiderpass, E ^w,x,y,z   Quiros J R ^aa   Zamora Ros, R ^ab   Sanchez M J ^ac,ad   Arriola, L ^ad,ae   Ardanaz, E ^ad,af   Tormo, M J ^ad,ag   Nilsson, P ^ah   Lindkvist, B ^ai   Sund, M ^aj   Rolandsson, O ^aj   Khaw, K T ^ak   Wareham, N ^al   Travis, R C ^am   Riboli, E ^u   Nothlings U ^a,an   more..

^a UNIVERSITY OF KIEL   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e EMORY UNIVERSITY   (United States)

^f Centre de Biologie Republique   (France)

^g AARHUS UNIVERSITY   (Denmark)

^h DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

ⁱ CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^j UNIVERSITÉ PARIS SACLAY   (France)

^k IGR   (France)

^l GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^m UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁿ HELLENIC HEALTH FOUNDATION   (Greece)

^o UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^p NATIONAL CANCER INSTITUTE   (Italy)

^q Human Genetics Foundation (HuGeF)   (Italy)

^r CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^s CIVILE M P AREZZO HOSPITAL   (Italy)

^t UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^u IMPERIAL COLLEGE LONDON   (United Kingdom)

^v NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^w UNIVERSITY OF TROMSØ   (Norway)

^x CANCER REGISTRY OF NORWAY   (Norway)

^y Cancer Registry of Norway ^*  (Sweden)

^z FOLKHÄLSAN RESEARCH CENTER   (Finland)

^aa Environmental Health Unit   (Spain)

^ab CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ac Andalusian School of Public Health   (Grenada)

^ad CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^ae Public Health Division of Gipuzkoa   (Spain)

^af INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ag DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^ah LUND UNIVERSITY   (Sweden)

^ai UNIVERSITY OF GOTHENBURG   (Sweden)

^aj UMEÅ UNIVERSITY   (Sweden)

^ak UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^al MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^am UNIVERSITY OF OXFORD   (United Kingdom)

^an UNIVERSITY OF BONN   (Germany)

more..

Author keywords

Biliary tract neoplasms; Diabetes duration; Diabetes mellitus; Gallbladder neoplasms; Hepatocellular carcinoma; Insulin treatment

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; EUROPE; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HEPATITIS B; HEPATITIS C; HUMAN; INSULIN TREATMENT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

BILIARY TRACT NEOPLASMS; DIABETES DURATION; DIABETES MELLITUS; GALLBLADDER NEOPLASMS; HEPATOCELLULAR CARCINOMA; INSULIN TREATMENT;

BILIARY TRACT NEOPLASMS; BODY COMPOSITION; BODY MASS INDEX; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS; EUROPE; FEMALE; HUMANS; INSULIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PROSPECTIVE STUDIES; RISK FACTORS; SELF REPORT;

EID: 84883398661     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt204     Document Type: Article

References (29)

1. Giovannucci E, Harlan DM, Archer MC et al. Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-1685.
2. Ren HB, Yu T, Liu C, et al. Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes Control 2011; 22: 837-847.
3. Wang C, Wang X, Gong G, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies. Int J Cancer 2012; 130: 1639-1648.
4. Wang P, Kang D, Cao W, et al. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev 2012; 28: 109-122.
5. Shebl FM, Andreotti G, Rashid A, et al. Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer 2010; 103: 115-119.
6. Weikert C, Weikert S, Schulze MB, et al. Presence of gallstones or kidney stones and risk of type 2 diabetes. Am J Epidemiol 2010; 171: 447-454.
7. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118: 1591-1602.
8. Petta S, Craxi A. Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. Curr Pharm Des 2010; 16: 741-752.
9. Schlesinger S, Aleksandrova K, Pischon T, et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer 2013; 132: 645-657.
10. Luo J, Chlebowski R, Liu S, et al. Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control 2013; 24: 577-585.
11. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468.
12. Atchison EA, Gridley G, Carreon JD, et al. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 2011; 128: 635-643.
13. Rousseau MC, Parent ME, Pollak MN, et al. Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 2006; 118: 2105-2109.
14. Polesel J, Zucchetto A, Montella M, et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol 2009; 20: 353-357.
15. Donadon V, Balbi M, Valent F, et al. Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. World J Gastroenterol 2010; 16: 3025-3032.
16. Hassan MM, Curley SA, Li D, et al. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer 2010; 116: 1938-1946.
17. La Vecchia C, Negri E, Decarli A, et al. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997; 73: 204-207.
18. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-1124.
19. Haftenberger M, Lahmann PH, Panico S, et al. Overweight, obesity and fat distribution in 50-to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2002; 5: 1147-1162.
20. Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 2005; 56: 303-307.
21. Trichopoulos D, Bamia C, Lagiou P, et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst 2011; 103: 1686-1695.
22. Adami HO, Chow WH, Nyren O, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996; 88: 1472-1477. 23. Jamal MM, Yoon EJ, Vega KJ, et al. Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol 2009; 15: 5274-5278.
23. Jamal MM, Yoon EJ, Vega KJ, et al. Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol 2009; 15: 5274-5278.
24. Carstensen B, Witte DR, Friis S. Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia 2012; 55: 948-958.
25. Chang CH, Lin JW, Wu LC, et al. Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus. J Clin Endocrinol Metab 2012; 97: E1170-E1175.
26. Wu J, Zhu AX. Targeting insulin-like growth factor axis in hepatocellular carcinoma. J Hematol Oncol 2011; 4: 30.
27. Bellentani S, Scaglioni F, Marino M, et al. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 155-161.
28. Turati F, Talamini R, Pelucchi C, et al. Metabolic syndrome and hepatocellular carcinoma risk. Br J Cancer 2013; 108: 222-228.
29. Huerta JM, Tormo MJ, Egea-Caparros JM, et al. Accuracy of self-reported diabetes, hypertension and hyperlipidemia in the adult Spanish population. DINO study findings. Rev Esp Cardiol 2009; 62: 143-152.